Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (EA-PPRN-00035)
Received: 27 May 2021
Accepted: 15 November 2021
First Online: 4 December 2021
: This study was performed in line with the principles of the Declaration of Helsinki and received Institutional Review Board approval from all participating institutions.
: Not applicable.
: BPY serves on advisory boards for Boehringer Ingelheim, AstraZeneca, GSK, Teva and Novartis. She has received research funding from GSK and Boehringer Ingelheim outside the scope of this study. Other authors declare no conflicts of interest.